United States · FDA National Drug Code directory
Tresiba
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0169-2550_e5571110-ca7e-4fcc-88a8-9f1d0104c508
- Product NDC
- 0169-2550
- Form
- INJECTION, SOLUTION
- Composition / generic term
- insulin degludec
- Labeler
- Novo Nordisk
- Marketing category
- BLA
- Marketing start / end (source format)
- 20150925
- Source listing expiry
- 20261231
Source-listed ingredients
- INSULIN DEGLUDEC — 200 U/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 3 SYRINGE, PLASTIC in 1 CARTON (0169-2550-13) / 3 mL in 1 SYRINGE, PLASTIC · 0169-2550-13
- 1 SYRINGE, PLASTIC in 1 CARTON (0169-2550-97) / 3 mL in 1 SYRINGE, PLASTIC (0169-2550-90) · 0169-2550-97
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →